摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(5-hydroxy-2-oxo-3-propionyl-2-H-pyran-6-yl)pentanol | 196193-61-0

中文名称
——
中文别名
——
英文名称
4-(5-hydroxy-2-oxo-3-propionyl-2-H-pyran-6-yl)pentanol
英文别名
4-(4-hydroxy-2-oxo-3-propionyl-2H-pyran-6-yl)pentanol;4-Hydroxy-6-(5-hydroxypentan-2-yl)-3-propanoylpyran-2-one
4-(5-hydroxy-2-oxo-3-propionyl-2-H-pyran-6-yl)pentanol化学式
CAS
196193-61-0
化学式
C13H18O5
mdl
——
分子量
254.283
InChiKey
KOKFNNCHPPAUQI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    421.9±45.0 °C(Predicted)
  • 密度:
    1.259±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    18
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    83.8
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] ANTIBACTERIAL AGENTS: ARYL MYXOPYRONIN DERIVATIVES<br/>[FR] AGENTS ANTIBACTÉRIENS : DÉRIVÉS ARYL MYXOPYRONINES
    申请人:UNIV RUTGERS
    公开号:WO2013192352A1
    公开(公告)日:2013-12-27
    The invention provides compounds of formula la, lb and Ic: [Formula Ia, Ib, and Ic] and salts thereof, wherein variables are as described in the specification, as well as compositions comprising a compound of formula Ia-Ic, methods of making such compounds, and methods of using such compounds, e.g., as inhibitors of bacterial RNA polymerase and as antibacterial agents.
    该发明提供了以下公式的化合物:[公式 Ia、Ib 和 Ic] 及其盐,其中变量如规范中所述,以及包含公式 Ia-Ic 化合物的组合物、制备这种化合物的方法以及使用这种化合物的方法,例如作为细菌RNA聚合酶的抑制剂和抗菌剂。
  • ANTIBACTERIAL AGENTS: SIDECHAINFLUORINATED MYXOPYRONIN DERIVATIVES
    申请人:RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    公开号:US20150051275A1
    公开(公告)日:2015-02-19
    The invention provides compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 3 R 4 , R 5 , and G are as described in the specification, as well compositions comprising a compound of formula I, methods of making such compounds, and methods of using such compounds, e.g., as inhibitors of bacterial RNA polymerase and as antibacterial agents.
    本发明提供了公式I的化合物及其药学上可接受的盐,其中R1、R2、R3、R4、R5和G如规范中所述。本发明还提供了包含公式I化合物的组合物、制备这种化合物的方法以及使用这种化合物的方法,例如作为细菌RNA聚合酶的抑制剂和抗菌剂。
  • ANTIBACTERIAL AGENTS: HIGH-POTENCY MYXOPYRONIN DERIVATIVES
    申请人:Ebright Richard H.
    公开号:US20130237595A1
    公开(公告)日:2013-09-12
    The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein Ya, Yb, R1, R2, and G are as described in the specification, as well as compositions comprising a compound of formula (I). The compounds are useful as inhibitors of bacterial RNA polymerase and as antibacterial agents.
    本发明提供了公式(I)的化合物及其药学上可接受的盐,其中Ya、Yb、R1、R2和G如规范所述,以及包含公式(I)化合物的组合物。这些化合物可用作细菌RNA聚合酶的抑制剂和抗菌剂。
  • ANTIBACTERIAL AGENTS: ARYL MYXOPYRONIN DERIVATIVES
    申请人:RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    公开号:US20150197512A1
    公开(公告)日:2015-07-16
    The invention provides compounds of formula la, lb and Ic: [Formula Ia, Ib, and Ic] and salts thereof, wherein variables are as described in the specification, as well as compositions comprising a compound of formula Ia-Ic, methods of making such compounds, and methods of using such compounds, e.g., as inhibitors of bacterial RNA polymerase and as antibacterial agents.
    本发明提供了公式la、lb和Ic的化合物:[公式Ia、Ib和Ic]及其盐,其中变量如规范所述,以及包含化合物Ia-Ic的组合物,制备这种化合物的方法和使用这种化合物的方法,例如作为细菌RNA聚合酶的抑制剂和抗菌剂。
  • Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation
    作者:Thomas Doundoulakis、Alan X. Xiang、Ricardo Lira、Konstantinos A. Agrios、Stephen E. Webber、Wes Sisson、Robert M. Aust、Amit M. Shah、Richard E. Showalter、James R. Appleman、Klaus B. Simonsen
    DOI:10.1016/j.bmcl.2004.08.045
    日期:2004.11
    A series of myxopyronin B analogs has been prepared via a convergent synthetic route and were tested for in vitro inhibitory activity against DNA-dependent RNA polymerase and antibacterial activity against E. coli and S. aureus. The parent lead compound proved to be very sensitive to even small changes. Only the achiral desmethyl myxopyronin B (1a) provided enhanced potency. (C) 2004 Elsevier Ltd. All rights reserved.
查看更多